ESM1 is known to be upregulated by inflammatory cytokines (IL-1β, TNF-α, and IFN-γ) and proangiogenic factors (VEGF-A and VEGF-C) and PI3K dependent pathway in cancer cell or endothelial cell [9,10,11,12]. This evidence concerns the gene IFNG and cancer.